- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
DCP2 Antibody / Post-Transcriptional Gene Regulator Antibody recognizes DCP2 (Decapping Protein 2), the catalytic enzyme responsible for removing the 5' cap structure from messenger RNA (mRNA), thereby initiating transcript degradation through the 5'-to-3' decay pathway. As the principal mRNA decapping enzyme in eukaryotic cells, DCP2 plays a fundamental role in post-transcriptional regulation of gene expression by controlling mRNA stability, transcript turnover, and protein production. Rather than regulating which genes are transcribed, DCP2 determines how long individual mRNA molecules remain available for translation, allowing cells to rapidly adjust protein synthesis in response to developmental, metabolic, and environmental signals. Clone PCRP-DCP2-1D6 has been validated by human protein microarray analysis, demonstrating exceptional specificity for DCP2 and providing confidence for applications requiring highly selective target detection.
DCP2 functions within cytoplasmic processing bodies (P-bodies), dynamic ribonucleoprotein granules that coordinate mRNA decapping, storage, translational repression, and degradation. Working together with DCP1, EDC proteins, RNA helicases, and the 5' exonuclease XRN1, DCP2 selectively targets transcripts for decay while preserving others needed for ongoing cellular activities. This regulated mRNA turnover allows precise control of cell proliferation, differentiation, stress adaptation, immune signaling, and developmental gene expression. By influencing transcript half-life rather than DNA transcription itself, DCP2 provides an additional layer of gene regulation that enables rapid and reversible changes in protein expression.
DCP2-mediated RNA turnover is essential for maintaining RNA quality control and eliminating defective, damaged, or no-longer-needed transcripts. The enzyme also contributes to cellular adaptation during oxidative stress, nutrient deprivation, viral infection, and other physiological challenges by selectively regulating the stability of stress-responsive mRNAs. Dysregulation of DCP2 or associated mRNA decay pathways has been implicated in cancer, neurodevelopmental disorders, inflammatory diseases, and viral pathogenesis, where abnormal transcript stability can alter signaling networks governing cell survival, proliferation, and differentiation. Because post-transcriptional regulation is increasingly recognized as a major determinant of gene expression, DCP2 has become an important target in molecular and translational research.
DCP2 Antibody / Post-Transcriptional Gene Regulator Antibody is a valuable tool for studies of RNA metabolism, mRNA turnover, transcript stability, RNA quality control, and post-transcriptional gene regulation. Researchers frequently use DCP2 Antibody / Post-Transcriptional Gene Regulator Antibody to investigate processing body biology, stress-responsive gene expression, RNA decay pathways, and mechanisms that coordinate gene expression during development and disease. The protein microarray-validated specificity of clone PCRP-DCP2-1D6 further supports its use in applications requiring accurate, reproducible, and highly specific detection of DCP2.
Explore our Cell Biology Antibodies page to learn more about proteins that regulate RNA metabolism, transcript stability, and post-transcriptional gene expression.
Optimal dilution of the DCP2 Antibody / Post-Transcriptional Gene Regulator Antibody should be determined by the researcher.
Recombinant full-length human protein was used as the immunogen for the Decapping Protein 2 antibody.
Aliquot the Decapping Protein 2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
DCP2 antibody, mRNA Decapping Enzyme antibody, Decapping Protein 2 antibody, RNA Decapping Enzyme antibody, P-Body Protein antibody, Post-Transcriptional Gene Regulator antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.